Archive
Broker spotlight, including AstraZeneca, DCC, Homeserve, Circle Oil, Motif Bio ...
US broker Jefferies reckons support services provider DCC (LON:DCC) is firing on all cylinders, and has hiked up the price target to 5,900p from 4,500p previously. The rating is 'buy'.